Abstract
Resistance to thyroid hormone beta (RTHβ) is a syndrome characterized by reduced responsiveness of peripheral tissues to thyroid hormone (TH). Affected individuals have consistently high TH levels and non-suppressed thyrotropin in the absence of acute illness, drugs, or alterations in TH binding proteins. Depending on the tissue, features of TH excess and deficiency may coexist, although most individuals have a euthyroid, normal metabolic state at the expense of high TH levels. In most cases the disorder is associated with germline mutations in the THRB gene. In the last decades, advances in genetics have expanded our knowledge on the etiology and pathophysiology of the syndrome and have shed more light on the molecular mechanisms of TH action. This review provides an update on the genetics of RTHβ, summarizes the clinical and biochemical presentation of the syndrome, and describes the methodology used to diagnose and manage individuals with RTHβ.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Refetoff S, DeWind LT, DeGroot LJ (1967) Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 27(2):279–294. https://doi.org/10.1210/jcem-27-2-279
Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ (1989) Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A 86(22):8977–8981
Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, Yen PM, Refetoff S (2017) Thyroid hormone signaling pathways. Time for a more precise nomenclature. Endocrinology 158(7):2052–2057. https://doi.org/10.1210/en.2017-00250
Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3):348–399. https://doi.org/10.1210/edrv-14-3-348
Lazar MA, Chin WW (1990) Nuclear thyroid hormone receptors. J Clin Invest 86(6):1777–1782. https://doi.org/10.1172/JCI114906
Lafranchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA, Nelson JC (2003) Follow-up of newborns with elevated screening T4 concentrations. J Pediatr 143(3):296–301. https://doi.org/10.1067/S0022-3476(03)00184-7
Takeda K, Sakurai A, DeGroot LJ, Refetoff S (1992) Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab 74(1):49–55. https://doi.org/10.1210/jcem.74.1.1727829
Weiss RE, Weinberg M, Refetoff S (1993) Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest 91(6):2408–2415. https://doi.org/10.1172/JCI116474
Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee KK (1994) Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest 94(2):506–515. https://doi.org/10.1172/JCI117362
Yoh SM, Chatterjee VK, Privalsky ML (1997) Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11(4):470–480. https://doi.org/10.1210/mend.11.4.9914
Collingwood TN, Wagner R, Matthews CH, Clifton-Bligh RJ, Gurnell M, Rajanayagam O, Agostini M, Fletterick RJ, Beck-Peccoz P, Reinhardt W, Binder G, Ranke MB, Hermus A, Hesch RD, Lazarus J, Newrick P, Parfitt V, Raggatt P, de Zegher F, Chatterjee VK (1998) A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. EMBO J 17(16):4760–4770. https://doi.org/10.1093/emboj/17.16.4760
Ando S, Sarlis NJ, Oldfield EH, Yen PM (2001) Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86(11):5572–5576. https://doi.org/10.1210/jcem.86.11.7984
Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ (1990) Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol 4(12):1988–1994. https://doi.org/10.1210/mend-4-12-1988
Ono S, Schwartz ID, Mueller OT, Root AW, Usala SJ, Bercu BB (1991) Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab 73(5):990–994. https://doi.org/10.1210/jcem-73-5-990
Frank-Raue K, Lorenz A, Haag C, Hoppner W, Boll HU, Knorr D, Hentze S, Raue F (2004) Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene. Eur J Endocrinol 150(6):819–823
Ferrara AM, Onigata K, Ercan O, Woodhead H, Weiss RE, Refetoff S (2012) Homozygous thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J Clin Endocrinol Metab 97(4):1328–1336. https://doi.org/10.1210/jc.2011-2642
Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 366(3):243–249. https://doi.org/10.1056/NEJMoa1110296
Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health prospective study. Ann Intern Med 123(8):572–583
Barkoff MS, Kocherginsky M, Anselmo J, Weiss RE, Refetoff S (2010) Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 95(7):3189–3193. https://doi.org/10.1210/jc.2009-2179
Campi I, Cammarata G, Bianchi Marzoli S, Beck-Peccoz P, Santarsiero D, Dazzi D, Bottari de Castello A, Taroni EG, Viola F, Mian C, Watuntantrige-Fernando S, Pelusi C, Muzza M, Maffini MA, Persani L (2017) Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHbeta). J Clin Endocrinol Metab 102(7):2620–2627. https://doi.org/10.1210/jc.2016-3671
Beck-Peccoz P, Chatterjee VK (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4(2):225–232. https://doi.org/10.1089/thy.1994.4.225
Weiss RE, Marcocci C, Bruno-Bossio G, Refetoff S (1993) Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab 76(1):257–259. https://doi.org/10.1210/jcem.76.1.8421095
Persani L, Borgato S, Romoli R, Asteria C, Pizzocaro A, Beck-Peccoz P (1998) Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 83(7):2486–2492. https://doi.org/10.1210/jcem.83.7.4970
Ercan-Fang S, Schwartz HL, Mariash CN, Oppenheimer JH (2000) Quantitative assessment of pituitary resistance to thyroid hormone from plots of the logarithm of thyrotropin versus serum free thyroxine index. J Clin Endocrinol Metab 85(6):2299–2303. https://doi.org/10.1210/jcem.85.6.6625
Anselmo J, Refetoff S (2004) Regression of a large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine. Thyroid 14(1):71–74. https://doi.org/10.1089/105072504322783876
Wu SY, Cohen RN, Simsek E, Senses DA, Yar NE, Grasberger H, Noel J, Refetoff S, Weiss RE (2006) A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 91(5):1887–1895. https://doi.org/10.1210/jc.2005-2428
Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P (1997) Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7(5):775–778. https://doi.org/10.1089/thy.1997.7.775
Takeda T, Suzuki S, Liu RT, DeGroot LJ (1995) Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 80(7):2033–2040. https://doi.org/10.1210/jcem.80.7.7608251
Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S (2004) Fetal loss associated with excess thyroid hormone exposure. JAMA 292(6):691–695. https://doi.org/10.1001/jama.292.6.691
Weiss RE, Dumitrescu A, Refetoff S (2010) Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endocrinol Metab 95(7):3094–3102. https://doi.org/10.1210/jc.2010-0409
Pappa T, Anselmo J, Mamanasiri S, Dumitrescu AM, Weiss RE, Refetoff S (2017) Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications. J Clin Endocrinol Metab. 1;102(10):3775–3782. https://doi.org/10.1210/jc.2017-01251
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pappa, T., Refetoff, S. (2018). Human Genetics of Thyroid Hormone Receptor Beta: Resistance to Thyroid Hormone Beta (RTHβ). In: Plateroti, M., Samarut, J. (eds) Thyroid Hormone Nuclear Receptor. Methods in Molecular Biology, vol 1801. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7902-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7902-8_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7901-1
Online ISBN: 978-1-4939-7902-8
eBook Packages: Springer Protocols